These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19164801)

  • 1. Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice.
    Koga J; Matoba T; Egashira K; Kubo M; Miyagawa M; Iwata E; Sueishi K; Shibuya M; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):458-64. PubMed ID: 19164801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury.
    Zhao Q; Egashira K; Hiasa K; Ishibashi M; Inoue S; Ohtani K; Tan C; Shibuya M; Takeshita A; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2284-9. PubMed ID: 15472126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor-induced osteopontin expression mediates vascular inflammation and neointima formation via Flt-1 in adventitial fibroblasts.
    Li XD; Chen J; Ruan CC; Zhu DL; Gao PJ
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2250-8. PubMed ID: 22814749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells.
    Ohtani K; Egashira K; Hiasa K; Zhao Q; Kitamoto S; Ishibashi M; Usui M; Inoue S; Yonemitsu Y; Sueishi K; Sata M; Shibuya M; Sunagawa K
    Circulation; 2004 Oct; 110(16):2444-52. PubMed ID: 15477409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer.
    Motomura Y; Kanbayashi H; Khan WI; Deng Y; Blennerhassett PA; Margetts PJ; Gauldie J; Egashira K; Collins SM
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G143-50. PubMed ID: 15297261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of vascular endothelial growth factor receptors (Flt-1 and Flk-1) in vascular adventitial fibroblasts.
    Jin X; Ge X; Zhu DL; Yan C; Chu YF; Chen WD; Liu J; Gao PJ
    J Mol Cell Cardiol; 2007 Sep; 43(3):292-300. PubMed ID: 17651752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
    Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.
    Izumi Y; Kim S; Yoshiyama M; Izumiya Y; Yoshida K; Matsuzawa A; Koyama H; Nishizawa Y; Ichijo H; Yoshikawa J; Iwao H
    Circulation; 2003 Dec; 108(22):2812-8. PubMed ID: 14638553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization.
    Lavin B; Gómez M; Pello OM; Castejon B; Piedras MJ; Saura M; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1739-46. PubMed ID: 24925976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
    Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
    Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury.
    Hutter R; Carrick FE; Valdiviezo C; Wolinsky C; Rudge JS; Wiegand SJ; Fuster V; Badimon JJ; Sauter BV
    Circulation; 2004 Oct; 110(16):2430-5. PubMed ID: 15477421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
    Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
    Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.
    Wang SH; Lin SJ; Chen YH; Lin FY; Shih JC; Wu CC; Wu HL; Chen YL
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):816-22. PubMed ID: 19342598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
    Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of embryonic lung vascular development by vascular endothelial growth factor receptors, Flk-1 and Flt-1.
    Yamamoto Y; Shiraishi I; Dai P; Hamaoka K; Takamatsu T
    Anat Rec (Hoboken); 2007 Aug; 290(8):958-73. PubMed ID: 17654674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation.
    Anggrahini DW; Emoto N; Nakayama K; Widyantoro B; Adiarto S; Iwasa N; Nonaka H; Rikitake Y; Kisanuki YY; Yanagisawa M; Hirata K
    Cardiovasc Res; 2009 Apr; 82(1):143-51. PubMed ID: 19164391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
    Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
    J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.